Biofrontera AG

Industry / private company


Location: Leverkusen, Germany (DE) DE

ROR: https://ror.org/03vtebn72

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy (2018) Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, et al. Journal article